HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dean Lim Selected Research

Dean Lim Research Topics

Disease

22Neoplasms (Cancer)
04/2024 - 12/2003
6Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 02/2014
5Neoplasm Metastasis (Metastasis)
11/2023 - 01/2020
3Appendiceal Neoplasms (Appendix Cancer)
11/2023 - 12/2022
3Nausea
12/2019 - 02/2007
3Vomiting
12/2019 - 02/2007
2Disease Progression
01/2023 - 04/2014
2Peritoneal Neoplasms
12/2022 - 12/2003
2Breast Neoplasms (Breast Cancer)
12/2019 - 11/2008
2Adenocarcinoma
12/2017 - 01/2016
2Squamous Cell Carcinoma of Head and Neck
11/2012 - 05/2009
2Esophageal Neoplasms (Esophageal Cancer)
12/2009 - 01/2007
1Pain (Aches)
12/2022
1Cytopenia
02/2020
1Hypersensitivity (Allergy)
12/2019
1Hypoxia (Hypoxemia)
12/2019
1Dizziness (Lightheadedness)
12/2019
1Lung Neoplasms (Lung Cancer)
12/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2019
1Liver Diseases (Liver Disease)
01/2019
1Ovarian Epithelial Carcinoma
01/2019
1Stomach Neoplasms (Stomach Cancer)
12/2017
1Chest Pain (Chest Pains)
12/2017
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
09/2014
1Vaccinia
09/2014
1Body Weight (Weight, Body)
08/2014
1Squamous Cell Neoplasms (Squamous Cell Cancer)
11/2012
1Fatigue
11/2012
1Exanthema (Rash)
11/2012
1Spinal Cord Neoplasms (Spinal Cord Tumors)
10/2010
1Memory Disorders (Memory Loss)
03/2007
1Ovarian Neoplasms (Ovarian Cancer)
02/2007
1Respiratory Insufficiency (Respiratory Failure)
02/2007
1Diarrhea
02/2007

Drug/Important Bio-Agent (IBA)

5Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2023 - 03/2007
4GemcitabineFDA Link
02/2020 - 02/2007
3Cetuximab (Erbitux)FDA Link
04/2014 - 11/2012
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 09/2004
2Yttrium-90IBA
02/2020 - 01/2020
2Carboplatin (JM8)FDA LinkGeneric
10/2010 - 11/2005
1IpilimumabIBA
01/2023
1regorafenibIBA
01/2023
1Programmed Cell Death 1 ReceptorIBA
01/2023
1NivolumabIBA
01/2023
1Mitomycin (Mitomycin-C)FDA LinkGeneric
12/2022
1Cisplatin (Platino)FDA LinkGeneric
01/2022
1Leucovorin (Folinic Acid)FDA Link
01/2022
1Fluorouracil (Carac)FDA LinkGeneric
01/2022
1Carcinoembryonic AntigenIBA
02/2020
1Indium-111IBA
02/2020
1tremelimumabIBA
01/2020
1Immune Checkpoint InhibitorsIBA
01/2020
1durvalumabIBA
01/2020
1Histone Deacetylase InhibitorsIBA
12/2019
1Isotretinoin (Accutane)FDA LinkGeneric
12/2019
1Tretinoin (Retinoic Acid)FDA LinkGeneric
12/2019
1belinostatIBA
12/2019
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2019
14-O-deacetyl vinorelbineIBA
01/2019
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2019
1130-nm albumin-bound paclitaxelIBA
01/2019
1Celecoxib (Celebrex)FDA Link
01/2019
1Angiogenesis InhibitorsIBA
01/2019
1BilirubinIBA
01/2019
1IT-101IBA
12/2017
1Irinotecan (Camptosar)FDA LinkGeneric
12/2017
1binimetinibIBA
10/2017
1PlatinumIBA
01/2016
1EverolimusFDA Link
01/2016
1MVA vaccineIBA
09/2014
1CALAA-01IBA
08/2014
1PolymersIBA
08/2014
1Small Interfering RNA (siRNA)IBA
08/2014
1Panitumumab (Vectibix)FDA Link
04/2014
1Monoclonal AntibodiesIBA
02/2014
1ErbB Receptors (EGF Receptor)IBA
02/2014
1Growth Factor ReceptorsIBA
02/2014
1pertuzumabIBA
02/2014
13-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA
03/2012
1Topotecan (Hycamtin)FDA LinkGeneric
10/2010
1TamoxifenFDA LinkGeneric
10/2010
1Bortezomib (Velcade)FDA Link
01/2010
1GTI2040IBA
11/2009
1Capecitabine (Xeloda)FDA Link
11/2009
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
11/2009
1Messenger RNA (mRNA)IBA
05/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2009
1VorinostatFDA Link
11/2008
1ribonucleotide reductase M2IBA
03/2007

Therapy/Procedure

14Drug Therapy (Chemotherapy)
04/2024 - 05/2004
8Therapeutics
01/2023 - 11/2005
2Cytoreduction Surgical Procedures
11/2023 - 01/2022
2Immunotherapy
01/2023 - 01/2019
2Hyperthermic Intraperitoneal Chemotherapy
12/2022 - 01/2022
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
12/2009 - 01/2007
2Radiotherapy
01/2007 - 05/2004
1Microspheres (Microsphere)
01/2020
1Aftercare (After-Treatment)
01/2020
1Image-Guided Radiotherapy
12/2009
1Combined Modality Therapy
05/2009